A randomized controlled trial of an implantable 2-channel peroneal nerve stimulator on walking speed and activity in poststroke hemiplegia
| Autor: | Martin J. B. Tenniglo, Hermie J. Hermens, A.I.R. Kottink, Maarten Joost IJzerman, Hans E. van der Aa, Anand V. Nene, H.P.J. Buschman |
|---|---|
| Přispěvatelé: | Faculty of Behavioural, Management and Social Sciences |
| Rok vydání: | 2007 |
| Předmět: |
Male
medicine.medical_specialty Physical Therapy Sports Therapy and Rehabilitation Electric Stimulation Therapy Hemiplegia Walking Sitting law.invention Randomized controlled trial law medicine Functional electrical stimulation Humans Stroke BSS-Electrical Neurostimulation business.industry Foot Rehabilitation Peroneal Nerve Equipment Design Middle Aged medicine.disease Gait Electrodes Implanted Preferred walking speed medicine.anatomical_structure Treatment Outcome Physical therapy Secondary Outcome Measure Exercise Test Female Ankle business human activities Follow-Up Studies |
| Zdroj: | Archives of physical medicine and rehabilitation, 88, 971-978. W.B. Saunders Ltd |
| ISSN: | 0003-9993 |
| Popis: | Objective: To determine the effect of a new implantable 2-channel peroneal nerve stimulator on walking speed and daily activities, in comparison with the usual treatment in chronic stroke survivors with a drop foot. - Design: Randomized controlled trial. - Setting: All subjects were measured 5 times in the gait laboratory. - Participants: Twenty-nine stroke survivors with chronic hemiplegia with drop foot who fulfill the predefined inclusion and exclusion criteria were included in the study. - Intervention: The intervention group received an implantable 2-channel peroneal nerve stimulator for correction of their drop foot. The control group continued using their conventional walking device, consisting of an ankle-foot orthosis, orthopedic shoes, or no device. - Main Outcome Measures: Walking speed, assessed both by a six-minute walk test (6MWT) and by using a 10-m walkway, was selected as primary outcome measure and activity monitoring data, consisting of percentage time spent on stepping, standing, and sitting/lying were selected as secondary outcome measure. - Results: Functional electric stimulation (FES) resulted in a 23% improvement of walking speed measured with the 6MWT, whereas the improvement in the control group was only 3% (P=.010). Comfortable walking speed measured on a 10-m walkway was also significantly improved in favor of FES (P=.038). The percentage time spent on stepping deteriorated with 3% in the intervention and 0.8% in control group, which was not statistically significant between both groups (P=.13). - Conclusions: The present study shows a clinically relevant effect of the implantable 2-channel peroneal nerve stimulator on walking speed in the sample of stroke survivors included in our study. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|